CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori. [electronic resource]
Producer: 19991206Description: 528-34 p. digitalISSN:- 0009-9236
- Amoxicillin -- therapeutic use
- Antacids -- therapeutic use
- Anti-Bacterial Agents -- therapeutic use
- Anti-Ulcer Agents -- pharmacology
- Aryl Hydrocarbon Hydroxylases
- Bismuth -- therapeutic use
- Clarithromycin -- therapeutic use
- Cytochrome P-450 CYP2C19
- Cytochrome P-450 Enzyme Inhibitors
- Cytochrome P-450 Enzyme System -- genetics
- Drug Therapy, Combination
- Enzyme Inhibitors -- pharmacology
- Gastritis -- drug therapy
- Genotype
- Helicobacter Infections -- drug therapy
- Helicobacter pylori -- drug effects
- Histamine H2 Antagonists -- therapeutic use
- Humans
- Metronidazole -- therapeutic use
- Mixed Function Oxygenases -- antagonists & inhibitors
- Omeprazole -- pharmacology
- Penicillins -- therapeutic use
- Peptic Ulcer -- drug therapy
- Polymerase Chain Reaction
- Polymorphism, Restriction Fragment Length
- Protein Synthesis Inhibitors -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.